Health Care Businesses

VIEWPOINT: CEOs, do you deserve your salaries?Restricted Content

June 22, 2009
John Guy
An exaggerated share of the nation's wealth is paid to CEOs of public companies, their minions and directors, through agreements made inside boardrooms, by highly compensated individuals who commit shareholders' money and are not subject to effective oversight.
More

Simple invention targets blanket problem for surgical patientsRestricted Content

May 25, 2009
Chris O'Malley
In a state steeped in advanced research that spawns biomedical companies by the dozen, Apricity LLC is preposterously low-tech, given that its latest product is nothing more than a warm blanket.
More

Obama's reforms could bite LillyRestricted Content

April 20, 2009
When it comes to health care reform, Eli Lilly and Co. has its derriere exposed more than its drugmaker peers.
More

Doctors should adapt to ratingsRestricted Content

April 13, 2009
Rating doctors via online services helps consumers make better health care decisions.
More

Doctors squirm as patients rate health careRestricted Content

April 6, 2009
J.K. Wall
As health care slowly shifts to operate more like retail stores, patients' opinions of doctors have become commonplace on more than 30 physician-rating Web sites, including a subscription service run by Indianapolis-based Angie's List.
More

Executives make many trips to Washington to argue for 14 years of sales exclusivity for new drugs made from cellsRestricted Content

March 23, 2009
J.K. Wall
Eli Lilly & Co. executives are making many trips to Washington to argue for 14 years of sales exclusivity for new drugs made from cells.
More

AIT Laboratories named 'Small Business of the Year'Restricted Content

March 2, 2009
The Indiana Chamber of Commerce has named Indianapolis-based health care research and testing firm AIT Laboratories its 2009 Small Business of the Year.
More

After two decades, future bright for Catheter Research Inc.Restricted Content

February 23, 2009
J.K. Wall
Catheter Research Inc. now is flying high—even in the midst of a bad economy.
More

Startup NICO raises another $1.73MRestricted Content

February 16, 2009
Indianapolis-based medical-device startup NICO Corp. has raised $1.73 million from investors.
More

Health care interests wary of state's cost-cutting idea for MedicaidRestricted Content

February 9, 2009
J.K. Wall
Indiana Medicaid officials want to take over management of all its patients' prescription drugs because they say it could save the state as much as $40 million a year.
More

Entrepreneurs pursuing patient advocacy trendRestricted Content

February 2, 2009
Christopher Lloyd
Patients are seeking help with their doctors, records and referrals as the health care system grows increasingly complex.
More

Stimulus could help medical exchangeRestricted Content

February 2, 2009

 President Barack Obama's economic stimulus bill provides a big opportunity for the Indianapolis-based Indiana Health Information Exchange to spread its expertise around the country.

More

Lilly settles Zyprexa marketing suit for $1.4 billion

January 15, 2009
J.K. Wall
Indianapolis-based Lilly pleaded guilty to one violation of the Food, Drug and Cosmetic Act on Thursday and agreed to pay $1.42 billion to settle both that criminal charge as well as civil lawsuits in which it did not admit wrongdoing.
More

My Health Care Manager goes nationalRestricted Content

December 15, 2008
Less than three years into its life, Indianapolis-based My Health Care Manager is going national.
More

Lilly fighting with generic drug firms over Cymbalta, Alimta, 5 other medicationsRestricted Content

December 8, 2008
J.K. Wall
Eli Lilly & Co. has filed lawsuits against seven generic drug companies in federal court in Indianapolis, asking a judge to declare its Cymbalta patent valid and to tell the generic companies to back off.
More

Billingsley markets health care mystery shopping businessRestricted Content

December 8, 2008
Della Pacheco
As co-founder and head of sales and marketing, Brooke Billingsley has helped build Indianapolis-based Perception Strategies Inc. — a health care mystery shopping business co-founded by her husband, Kevin.
More

Eli Lilly investing $100M in China, hoping to attract research partners

December 1, 2008
Brian Spegele
Hoping to increase sales in China's rapidly growing pharmaceutical market, Eli Lilly and Co. is charging ahead with plans to invest $100 million in venture capital in the region over the next several years.
More

Despite sour economy, retail developers press onRestricted Content

December 1, 2008
Greg AndrewsMore

Indianapolis eye surgeon popularizes new transplant techniqueRestricted Content

November 10, 2008
J.K. Wall
Dr. Francis Price Jr. has brought hundreds of eye surgeons to Indianapolis to train them in how to use a new cornea transplant technique that has swept the ophthalmology field—DSEK, which stands for Descemet's stripping endothelial keratoplasty.
More

St. Francis Hospitals, Anthem disagree over health insurance reimbursementsRestricted Content

November 10, 2008
The St. Francis hospital system and Anthem Blue Cross and Blue Shield of Indiana are haggling over insurance reimbursement costs. The original demand of Sisters of St. Francis Health Services Inc. would have increased reimbursement amounts $80 million over three years, Rick Rhodes, an Anthem regional vice president, wrote in an Oct. 30 letter to employers covered by Anthem. The increase would mean $12 million more in out-of-pocket costs to Anthem customers. But St. Francis claims its request for an increase only brings it in line with what other hospitals are getting.
More

Lilly buys ImClone as part of strategy to capitalize on cancer-drug marketRestricted Content

October 13, 2008
J.K. Wall

Eli Lilly and Co. has written a $6.5 billion IOU to acquire the cancer drugs of ImClone Systems Inc. Cancer drugs are now the best-selling class of drugs in the world and one of the fastest growing.


More

Lilly taps hedge fund to cut research costs for Alzheimer's drugsRestricted Content

August 11, 2008
J.K. Wall

Eli Lilly and Co.'s unorthodox efforts to develop new treatments for Alzheimer's disease--if successful--could usher in a new approach to drug development. The Indianapolis-based pharmaceutical company announced that a New York hedge fund, TPG-Axon Capital, will invest up to $325 million to help cover the exorbitant development costs of two experimental compounds to treat Alzheimer's disease.

More

Lilly expects FDA approval of long-acting version of ZyprexaRestricted Content

February 4, 2008
J.K. Wall
Eli Lilly and Co. hopes to extend the life of its best-seller Zyprexa with a potentially lucrative, long-acting form of the antipsychotic drug. But first, the Indianapolis-based drugmaker must win over a panel of medical experts convened by the U.S. Food and Drug Administration on Feb. 6.
More

Taurel passes the batonRestricted Content

December 31, 2007
J.K. Wall
A new leader will guide the city's largest company in 2008, with some of the biggest challenges in its history on the horizon. Eli Lilly and Co. announced Dec. 18 that CEO Sidney Taurel will step down March 31 and will be replaced by President John C. Lechleiter, who has been the heir apparent for more than two years.
More

Taurel helped Lilly weather Prozac defeat, but he also stumbledRestricted Content

December 24, 2007
J.K. Wall
When Eli Lilly and Co. CEO Sidney Taurel announced his retirement Dec. 18, he said he was leaving the company in good shape. And he can cite plenty of evidence to support him. But when Taurel steps down as CEO March 31, he also will leave a legacy of a languishing stock price and some costly mistakes that some think could have been avoided. "The facts are the facts; I guess you can't ignore it. The stock price has been...
More
Page  << 21 22 23 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT